Seeking Alpha

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial ...
ascopubs.org

Self-Supervised Transformer-Based Pipeline for Liver Tumor Segmentation and Type Classification

First, we pretrained the encoder of a transformer-based network using a self-supervised approach on unlabeled abdominal computed tomography images. Subsequently, we fine-tuned the segmentation network ...
News Medical

Detecting hepatotoxic drugs with human liver microtissues

This article is based on a poster originally authored by L. Fäs, F. Wenz, M. Tu, K. Sanchez, N. Zapiórkowska-Blumer, H. Varga and K. Kaczmarska, which was presented at ELRIG Drug Discovery 2024 in ...
Health.com

Signs and Symptoms of Liver Disease

Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...
Morningstar

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show potential of efimosfermin to reverse liver ...